The post Metallica Joins AC/DC, Disturbed And Black Sabbath With A Comeback appeared on BitcoinEthereumNews.com. Metallica’s “Enter Sandman” reenters Billboard’s Hard Rock Digital Song Sales chart at No. 9, joining comebacks from AC/DC, Disturbed and Black Sabbath. (MANDATORY CREDIT Koh Hasebe/Shinko Music/Getty Images) Metallica in photo session at a hotel, Tokyo, November 1986. (Photo by Koh Hasebe/Shinko Music/Getty Images) Getty Images Billboard’s Hard Rock Digital Song Sales chart experiences quite the shake-up this week, with several classics of the genre returning. That includes one time-tested smash from Metallica, which reappears to claim a spot inside the top 10. “Enter Sandman” Becomes a Top 10 Bestseller “Enter Sandman” is once again counted among the bestselling hard rock tracks in the U.S. This frame, it reenters the Hard Rock Digital Song Sales chart at No. 9. The former No. 1 has now spent 705 weeks somewhere on the tally, which these days only features 10 spaces, making it an extremely competitive ranking. “Enter Sandman” Lives Inside the Top 10 on Several Charts At the same time that it breaks onto the sales ranking again, “Enter Sandman” can also be found on the Hard Rock Streaming Songs chart, where it climbs from No. 8 to No. 6. Unlike on the purchase-only tally tally, however, Metallica’s classic has never made it to No. 1 on streaming. The beloved tune only rose as high as No. 3 in the 273 weeks it’s spent on the roster. A 35-Year-Old Metallica Smash “Enter Sandman” was a big hit when Metallica released it decades ago, and in the years since, it has become not only a standard in the band’s discography, but one of the most successful hard rock cuts of all time. The fact that the nearly 35-year-old blockbuster appears inside the top 10 on multiple Billboard charts underlines its sustained popularity. Metallica’s Self-Titled Album Rebounds “Enter Sandman” served as the lead… The post Metallica Joins AC/DC, Disturbed And Black Sabbath With A Comeback appeared on BitcoinEthereumNews.com. Metallica’s “Enter Sandman” reenters Billboard’s Hard Rock Digital Song Sales chart at No. 9, joining comebacks from AC/DC, Disturbed and Black Sabbath. (MANDATORY CREDIT Koh Hasebe/Shinko Music/Getty Images) Metallica in photo session at a hotel, Tokyo, November 1986. (Photo by Koh Hasebe/Shinko Music/Getty Images) Getty Images Billboard’s Hard Rock Digital Song Sales chart experiences quite the shake-up this week, with several classics of the genre returning. That includes one time-tested smash from Metallica, which reappears to claim a spot inside the top 10. “Enter Sandman” Becomes a Top 10 Bestseller “Enter Sandman” is once again counted among the bestselling hard rock tracks in the U.S. This frame, it reenters the Hard Rock Digital Song Sales chart at No. 9. The former No. 1 has now spent 705 weeks somewhere on the tally, which these days only features 10 spaces, making it an extremely competitive ranking. “Enter Sandman” Lives Inside the Top 10 on Several Charts At the same time that it breaks onto the sales ranking again, “Enter Sandman” can also be found on the Hard Rock Streaming Songs chart, where it climbs from No. 8 to No. 6. Unlike on the purchase-only tally tally, however, Metallica’s classic has never made it to No. 1 on streaming. The beloved tune only rose as high as No. 3 in the 273 weeks it’s spent on the roster. A 35-Year-Old Metallica Smash “Enter Sandman” was a big hit when Metallica released it decades ago, and in the years since, it has become not only a standard in the band’s discography, but one of the most successful hard rock cuts of all time. The fact that the nearly 35-year-old blockbuster appears inside the top 10 on multiple Billboard charts underlines its sustained popularity. Metallica’s Self-Titled Album Rebounds “Enter Sandman” served as the lead…

Metallica Joins AC/DC, Disturbed And Black Sabbath With A Comeback

Metallica’s “Enter Sandman” reenters Billboard’s Hard Rock Digital Song Sales chart at No. 9, joining comebacks from AC/DC, Disturbed and Black Sabbath. (MANDATORY CREDIT Koh Hasebe/Shinko Music/Getty Images) Metallica in photo session at a hotel, Tokyo, November 1986. (Photo by Koh Hasebe/Shinko Music/Getty Images)

Getty Images

Billboard’s Hard Rock Digital Song Sales chart experiences quite the shake-up this week, with several classics of the genre returning. That includes one time-tested smash from Metallica, which reappears to claim a spot inside the top 10.

“Enter Sandman” Becomes a Top 10 Bestseller

“Enter Sandman” is once again counted among the bestselling hard rock tracks in the U.S. This frame, it reenters the Hard Rock Digital Song Sales chart at No. 9. The former No. 1 has now spent 705 weeks somewhere on the tally, which these days only features 10 spaces, making it an extremely competitive ranking.

“Enter Sandman” Lives Inside the Top 10 on Several Charts

At the same time that it breaks onto the sales ranking again, “Enter Sandman” can also be found on the Hard Rock Streaming Songs chart, where it climbs from No. 8 to No. 6. Unlike on the purchase-only tally tally, however, Metallica’s classic has never made it to No. 1 on streaming. The beloved tune only rose as high as No. 3 in the 273 weeks it’s spent on the roster.

A 35-Year-Old Metallica Smash

“Enter Sandman” was a big hit when Metallica released it decades ago, and in the years since, it has become not only a standard in the band’s discography, but one of the most successful hard rock cuts of all time. The fact that the nearly 35-year-old blockbuster appears inside the top 10 on multiple Billboard charts underlines its sustained popularity.

Metallica’s Self-Titled Album Rebounds

“Enter Sandman” served as the lead single from Metallica’s self-titled fifth full-length, which is sometimes referred to as The Black Album. That project continues to live on multiple album rankings in America. This week, Metallica lands at No. 14 on the Top Hard Rock Albums chart and at No. 185 on the Billboard 200. The project even manages to ascend seven spaces on the Top Rock & Alternative Albums chart, nearly breaking back into the top 40 as it climbs to No. 42.

AC/DC, Disturbed and Black Sabbath Join Metallica

Four tunes return to the Hard Rock Digital Song Sales chart this week. The roundup is led by AC/DC’s “Thunderstruck” at No. 5, followed by Disturbed’s “The Sound of Silence” cover (No. 7) and “War Pigs/Luke’s Wall” by Black Sabbath (No. 10).

Source: https://www.forbes.com/sites/hughmcintyre/2025/08/31/metallica-joins-acdc-disturbed-and-black-sabbath-with-a-comeback/

Market Opportunity
Seed.Photo Logo
Seed.Photo Price(PHOTO)
$0.31151
$0.31151$0.31151
0.00%
USD
Seed.Photo (PHOTO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26